Boston Scientific : 2023 Performance Report

2023 Performance Report

Advancing Science for Life

Introduction	Innovative care	Empowered people	Healthier planet	Performance with integrity	Appendix

Introduction

Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.

In this section:

03//  From pain to possibility: Erika's story

05//  A message from our Chairman and Chief Executive Officer 07//  Boston Scientific: 2023 at a glance

08//  Corporate responsibility at Boston Scientific

10//  2023 corporate responsibility highlights

11//  Awards and recognition

2023 Performance Report

2

Introduction	Innovative care	Empowered people	Healthier planet	Performance with integrity	Appendix

From pain to possibility, an 84-year-old fitness icon shows how it's done

Erika Rischko, a self-described84-year-old exercise fanatic, has hundreds of thousands of TikTok and Instagram followers who are inspired by her plank challenges, burpees and other physical feats. "I enjoy doing new things and testing out

my limits," says Erika, who joined a local gym in Langenfeld, Germany, at 55 and quickly advanced to high-intensity challenges like trampolining and boxing.

But before becoming a viral fitness sensation, Erika battled chronic back pain that started in 2017. Erika took various medications, but experienced negative side effects. "My quality of life was severely impacted before the procedure. I could barely stroll through the city without frequent stops."

"It gives me joy to be able to work out, inspire others and even help people who may be in a similar situation. I never dreamed it, and I am very grateful."

Erika Rischko

Boston Scientific patient

She struggled to find relief until learning about spinal cord stimulation (SCS). In this treatment, a small implanted devicesends mild electrical pulses that interrupt pain signals before they reach the brain. Almost immediately, Erika was relieved of her pain and soon after was back inspiring her followers, gaining internet celebrity status and making TV appearancesaround the world. "Now look at me! I run around, do all sorts of things and can live my life the way I like it." In 2020, Erika held a plank for eight minutes and 40 seconds -

a personal milestone.

Erika uses her experience and reach to raise awareness about chronic pain and SCS as a treatment to manage it.

"It gives me joy to be able to work out, inspire others and even help people who may be in a similar situation. I never dreamed it, and I am very grateful." At Boston Scientific, we are grateful to Erika, her doctors and so many other patients who inspire us every day to push the boundaries of science to help people live longer, healthier lives.

To learn more about chronic pain and treatment methods, visit www.pain.com.

2023 Performance Report

3

Introduction	Innovative care	Empowered people	Healthier planet	Performance with integrity	Appendix

Table of contents

Introduction			2
From pain to possibility: Erika's story		3
A message from our Chairman and Chief Executive Officer		5
Boston Scientific: 2023 at a glance			7
Corporate responsibility at Boston Scientific			8
2023 corporate responsibility highlights			10
Awards and recognition			11

Innovative care		12
Innovating to improve patient lives			13
Ensuring quality, health and safety			20
Advancing health access and equity			22

Empowered people		25
Developing our global workforce			26
Fostering a diverse, equitable and inclusive workplace			32
Caring for our employees			35
Working with our communities			37

Healthier planet		39
Our path to net zero			40
Embedding product stewardship			46
Addressing water, waste and biodiversity			47
Managing climate risk			48

Performance with integrity		49
Governance and compliance			50
Risk management			52
Cybersecurity			53
Responsible supply chain			54

Appendix		56
Materiality			57
Stakeholder engagement			58
Metrics summary			59
Global Reporting Initiative index			69
Sustainability Accounting Standards Board index			76
Task Force on Climate-related Financial Disclosures index			78
United Nations Sustainable Development Goals			81

FARAPULSE™ Pulsed Field Ablation System

This report has been prepared with reference to the Global Reporting Initiative (GRI) Standards as well as alignment with the Sustainability Accounting Standards Board (SASB) standards for the Medical Equipment & Supplies industry and the Task Force on Climate-related Financial Disclosures (TCFD) recommendations. Unless otherwise indicated, data in this 2023 Performance Report and appendix are as of, or for the year ended, December 31, 2023, as applicable. Please refer to the appendix for detailed metrics and key definitions used within this report.

Reporting on other matters specific to financial performance of the company and its subsidiaries can be found in our 2023 Annual Report.

2023 Performance Report

4

Introduction	Innovative care	Empowered people	Healthier planet	Performance with integrity	Appendix

A message from our Chairman and Chief Executive Officer

At Boston Scientific, improving patient health is the cornerstone of everything we do. And because we know that patient health is interconnected with the health of communities and of the planet, we take seriously our responsibility to make progress toward environmental, social and governance goals - and to continue to hold ourselves accountable. That dedication is shared by our more than 48,000 employees worldwide, whose talent and commitment to the highest standards of quality allows us to raise the bar, year after year.

Our 2023 business results demonstrate high performance across our company. Our teams launched nearly 90 products, expanded our digital and operational capabilities and accelerated research and development (R&D) to fuel our innovation pipeline. We advanced health and addressed inequities by increasing diversity in clinical trials, donating

more than $76 million to fund global medical research, fellowships, education and charitable organizations as well as through increasing the diversity of our workforce. Since a healthier planet leads to healthier people, we achieved 82% renewable electricity,1 bringing us closer to our goal of 100% by the end of 2024. Our teams also further defined our path to net-zero greenhouse gas emissions across our value chain by 2050. Most importantly, we worked together to help improve the lives of more than 37 million patients around the world.

There is always more progress to be made and I know that with the values-driven culture we have built, our global teams remain committed to the invigorating work of challenging what's possible. Together, we'll continue to deliver on our mission to transform lives through innovative medical solutions.

Mike Mahoney

Chairman and Chief Executive Officer,

Boston Scientific

"Because we know that patient health is interconnected with the health of communities and of the planet, we take seriously our responsibility to make progress toward environmental, social and governance goals - and to continue to hold ourselves accountable."

1 Includes renewable electricity generated onsite and purchased electricity matched with electricity from renewable sources. Inclusive of all manufacturing and key distribution sites only.

2023 Performance Report

5

Introduction	Innovative care	Empowered people	Healthier planet	Performance with integrity	Appendix

Our work is guided by core values that define the Boston Scientific culture and empower our employees.

Caring

We act with integrity and compassion to support patients, customers, communities, the planet and each other.

High performance

We strive for high performance to benefit patients, customers, shareholders and employees.

Diversity

We embrace diversity, equity and inclusion, valuing unique ideas and experiences.

Global collaboration

We work collaboratively to pursue global opportunities that extend the reach of our medical solutions.

Meaningful innovation

We transform new ideas into breakthrough services and sustainable solutions that create value.

Winning spirit

We adapt to change and act with speed, agility and accountability to further improve patient care.

2023 Performance Report

6

Introduction	Innovative care	Empowered people	Healthier planet	Performance with integrity	Appendix

Boston Scientific: 2023 at a glance

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care.

To learn more about our category leadership strategy and growth opportunities, visit our Investor Relations website.

2023 net sales by business

(dollars in millions)

Cardiovascular

Cardiology

$6,709

2023 net sales by region

(dollars in millions)

	U.S.	$8,425
	EMEA (Europe, Middle East and Africa)	$2,856	$14,240
	APAC (Asia-Pacific)	$2,400
	LACA (Latin America and Canada)	$560	million
Net Sales	$14,240

			MedSurg
Peripheral
	Endoscopy	Urology	Neuromodulation
Interventions
$2,110	$2,482	$1,964	$976

Cardiac Rhythm	Electrophysiology	Interventional	Watchman
Management	Cardiology Therapies

Amounts may not add up due to rounding.

2023 Performance Report

7

Introduction	Innovative care	Empowered people	Healthier planet	Performance with integrity	Appendix

Corporate responsibility at Boston Scientific

We are committed to transparency in environmental, social and governance (ESG) progress and continually work to improve our reporting as industry best practices evolve. Our report's three focus areas address how we innovate to meet patient needs, empower people and shape a healthier planet, anchored by how we do business with integrity. The framework reflects our material topics and helps us further engage with stakeholders.

Our strategy and approach

As a global health care company, our commitment to meet patient needs comes with a responsibility to protect and contribute to the world we share. We prioritize integrating ESG opportunities while mitigating risks into our business practices, and the insights we gain from this guides our progress.

Our approach to ESG is aligned with the United Nations Sustainable Development Goals, and we have identified material topicsthat enable us to have the greatest impact.

Innovative care

We shape science into meaningful solutions that help people live longer, better lives.

Empowered people

We invest in our people and unite our diverse communities through global collaboration.

Healthier planet

We confront climate change and protect the environment to enable people to live healthier lives.

To deliver meaningful results, subject matter experts and key advisors across our company work closely with our ESG team to determine how we measure and share progress on our environmental, social and governance performance. The vice president of ESG leads our global ESG vision and strategy and reports to the chair of the ESG Executive Steering Committee, composed of nine Executive Committee members. The vice president of ESG regularly updates our Board of Directors and its Nominating and Governance Committee, which oversees the company's ESG initiatives.

Performance with integrity

Governance and compliance | Risk management | Cybersecurity | Responsible supply chain

2023 Performance Report

8

Introduction	Innovative care	Empowered people	Healthier planet	Performance with integrity	Appendix

Engaging our stakeholders

Our ESG strategy, priorities and practices are informed by conversations with diverse stakeholders inside and outside the company - locally, nationally and globally. In our collaborations and other business relationships, we work with organizations that share our commitment to better understand and improve environmental, social and economic progress.

Learn more about our material topicsand stakeholder engagement efforts.

Linking compensation to ESG performance

A message from Kathryn Unger, Vice President of Environmental, Social and Governance

The importance of our ESG efforts is reinforced by a companywide scorecard that is part of our annual employee bonus program and demonstrates our commitment to hold ourselves accountable to our goals in a measurable way. In 2023, the ESG scorecard was weighted at 15% of our total bonus pool funding and equally divided among three ESG performance metrics: diversity, equity and inclusion (DE&I); employee engagement; and environmental performance.

To learn more about our performance, please see the company's 2024 Proxy Statement.

Our ESG work is rooted in our core values. We focus on the areas where we believe we can make the greatest difference for the people we serve and the world we share.

Whether it's innovating care to help people live longer, better lives; empowering people by advancing DE&I in our workplace and communities; or enabling a healthier planet, we are committed to making sustainable progress. This report describes how our teams apply the science and innovation that define our business

to advance our ESG priorities and goals.

We are not alone on this dynamic journey. We gather and consider many perspectives to deepen our knowledge and increase our agility, and we collaborate with our customers and other stakeholders to address the full scope of needs this work requires.

The path to greater progress takes time. Every day I am grateful to, and inspired by, the commitment of our employees around the world to do more for our patients, customers and employees, as well as for our communities and planet. It is through deliberate action and enduring engagement that we will continue to find new and better ways to advance science for life.

2023 Performance Report

9

Introduction	Innovative care	Empowered people	Healthier planet	Performance with integrity	Appendix

2023 corporate responsibility highlights

Innovative		Empowered		Healthier
care		people		planet
37M+	$1.4B	99%+	43.5%	82%	77%
patients served	annual R&D spend1	pay equity	women in mid-level	renewable electricity3,4	solid, non-hazardous
			leadership2 roles (global)		waste recycled3

Zero findings	$76M+	22.6%
resulting in action following	contributions for medical	multicultural talent in
over 415 external audit days	research, fellowships,	mid-level leadership2
	education and charitable	roles (U.S./Puerto Rico)
	organizations globally

72%

real estate independently certified for energy efficiency5

Performance with integrity

40M+	99%+	~$340M
products delivered in 2023	of employees completed Code of Conduct training	spent on small and diverse suppliers

1. Represents GAAP R&D expense per Annual Report on Form 10-K.
2. Mid-levelleadership includes managers, principals, senior managers and fellows.
3. Inclusive of all manufacturing and key distribution sites only.

1. Includes renewable electricity generated onsite and purchased electricity matched with electricity from renewable sources.
2. Percentage of all Boston Scientific real estate (including commercial, leased and owned) that is independently certified for energy efficiency

by industry-leading bodies such as LEED for design and Energy Star or ISO 50001:2018 for building operations.

2023 Performance Report

10